<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>MedicalCRITERIA.com</provider_name><provider_url>https://medicalcriteria.com/web/es</provider_url><author_name>Guillermo Firman</author_name><author_url>https://medicalcriteria.com/web/es/author/medicalcriteria-com/</author_url><title>Criterios Diagn&#xF3;stico para S&#xED;ndrome Linfoproliferativo Autoinmune - MedicalCRITERIA.com</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="93cz4m3eWm"&gt;&lt;a href="https://medicalcriteria.com/web/es/hemalps/"&gt;Criterios Diagn&#xF3;stico para S&#xED;ndrome Linfoproliferativo Autoinmune&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://medicalcriteria.com/web/es/hemalps/embed/#?secret=93cz4m3eWm" width="600" height="338" title="&#xAB;Criterios Diagn&#xF3;stico para S&#xED;ndrome Linfoproliferativo Autoinmune&#xBB; &#x2014; MedicalCRITERIA.com" data-secret="93cz4m3eWm" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>El s&#xED;ndrome linfoproliferativo autoinmune (ALPS) se caracteriza por la desregulaci&#xF3;n del sistema inmune debido a la incapacidad de regular la homeostasis de los linfocitos mediante el proceso de apoptosis de los linfocitos (una forma de muerte celular programada). Las consecuencias de esto incluyen la enfermedad linfoproliferativa, manifestada por linfadenopat&#xED;a, hepatomegalia, esplenomegalia y un mayor riesgo [&hellip;]</description></oembed>
